SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+10.3%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.65B
AUM Growth
+$2.65B
(+7.4%)
Cap. Flow
-$10.1M
Cap. Flow
% of AUM
-0.38%
Top 10 Holdings %
Top 10 Hldgs %
40.85%
Holding
111
New
10
Increased
29
Reduced
18
Closed
14
Top Buys
| 1 |
Coca-Cola
KO
|
$57.8M |
| 2 |
Dick's Sporting Goods
DKS
|
$51.5M |
| 3 |
GE HealthCare
GEHC
|
$39.4M |
| 4 |
Danaher
DHR
|
$31.8M |
| 5 |
GE Aerospace
GE
|
$28.2M |
Top Sells
| 1 |
Insmed
INSM
|
$126M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$92.5M |
| 3 |
Microsoft
MSFT
|
$40.4M |
| 4 |
United Airlines
UAL
|
$28.3M |
| 5 |
Chipotle Mexican Grill
CMG
|
$27.1M |
Sector Composition
| 1 | Healthcare | 61.21% |
| 2 | Technology | 12.36% |
| 3 | Consumer Discretionary | 7.05% |
| 4 | Financials | 6.14% |
| 5 | Communication Services | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Rocket Pharmaceuticals
RCKT
$354M
| $10.2M | 0.31% |
4,143,333
+641,333
| +18% | +$1.57M |
|
|
MOLN
52
Molecular Partners
MOLN
$140M
| $8.49M | 0.26% |
2,221,494
| – | – |
|
53
Taysha Gene Therapies
TSHA
$797M
| $7.43M | 0.22% |
+3,217,449
| New | +$7.43M |
|
54
ProKidney
PROK
$319M
| $7.31M | 0.22% |
12,341,266
| – | – |
|
|
WHWK
55
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $6.92M | 0.21% |
3,700,000
| – | – |
|
|
CTNM
56
Contineum Therapeutics
CTNM
$293M
| $6.83M | 0.21% |
1,720,000
| – | – |
|
57
Abbott
ABT
$231B
| $5.51M | 0.17% |
40,520
-18,300
| -31% | -$2.49M |
|
58
InflaRx
IFRX
$108M
| $5.12M | 0.15% |
6,483,910
| – | – |
|
59
Zura Bio
ZURA
$133M
| $5.1M | 0.15% |
4,860,939
| – | – |
|
60
Exact Sciences
EXAS
$8.98B
| $5M | 0.15% |
94,100
| – | – |
|
61
Sutro Biopharma
STRO
$72.7M
| $4.63M | 0.14% |
6,488,324
-974,171
| -13% | -$695K |
|
62
Regeneron Pharmaceuticals
REGN
$61.5B
| $4.53M | 0.14% |
+8,630
| New | +$4.53M |
|
63
Cencora
COR
$56.5B
| $3.74M | 0.11% |
12,488
| – | – |
|
64
Elanco Animal Health
ELAN
$9.12B
| $3.62M | 0.11% |
253,600
| – | – |
|
65
Kezar Life Sciences
KZR
$28.9M
| $3.28M | 0.1% |
716,759
| – | – |
|
66
Thermo Fisher Scientific
TMO
$186B
| $3.2M | 0.1% |
7,900
| – | – |
|
67
Intuitive Surgical
ISRG
$170B
| $2.83M | 0.09% |
5,200
| – | – |
|
68
DexCom
DXCM
$29.5B
| $2.77M | 0.08% |
31,680
| – | – |
|
69
Stryker
SYK
$150B
| $2.32M | 0.07% |
5,860
| – | – |
|
70
Mettler-Toledo International
MTD
$26.8B
| $2.31M | 0.07% |
1,964
| – | – |
|
71
Medtronic
MDT
$119B
| $2.18M | 0.07% |
25,060
| – | – |
|
72
Natera
NTRA
$23.1B
| $1.71M | 0.05% |
10,100
| – | – |
|
73
McKesson
MCK
$85.4B
| $1.34M | 0.04% |
1,830
| – | – |
|
74
Wingstop
WING
$9.16B
| $1.33M | 0.04% |
+3,961
| New | +$1.33M |
|
75
HCA Healthcare
HCA
$94.5B
| $1.22M | 0.04% |
3,190
| – | – |
|